NMSU branding

New Mexico State University

New Mexico State University

News Center

Research Rally will honor NMSU leaders awarded for a great IDeA

WHAT: New Mexico IDeA Networks of Biomedical Research Excellence, funded by the Institutional Development Award (IDeA) from the National Institutes of Health

WHO: Regents Professor Jeffrey Arterburn, principal investigator, and his team

WHEN: 9 a.m. Friday, Feb. 10

WHERE: O'Donnell Hall Room 104

VISUALS: There will be poster boards set up to complement the speakers.

New Mexico State University will hold its next Research Rally at 9 a.m. Friday, Feb. 10, at O'Donnell Hall, Room 104. The rally will honor the New Mexico IDeA Networks of Biomedical Research Excellence (NM-INBRE) program, which expanded in 2009 thanks to a five-year $17.5 million grant awarded by the National Institutes of Health.

The program's pilot phase, New Mexico Biomedical Research Infrastructure Network, started in 2001, was created to strengthen biomedical research in New Mexico's institutions of higher education and to prepare faculty and students for participation in the research programs of the NIH. The network includes NMSU's partner institutions, the University of New Mexico, Eastern New Mexico University, New Mexico Institute of Mining and Technology and New Mexico Highlands University. It also includes the non-profit National Center for Genome Resources in Santa Fe.

For its second phase, the program has expanded the network of partner institutions to include San Juan College in Farmington and The Dialysis Clinic, Inc. of Albuquerque. The Dialysis Clinic is currently working on a community-based research project that could identify possible genetic, environmental and cultural interactions that negatively affect health conditions in Native Americans in a study called the Zuni Health Initiative.

The $17.5 million funding was provided by the National Center for Research Resources, a division of the NIH, as part of a competitive $122 million award to IDeA-eligible states, which are states that historically have not received significant NIH funding.

NMSU students, faculty and staff as well as the media are invited to attend. The lead investigators will discuss the latest developments in their work with NM-INBRE. They will also be available to answer questions.

There will be an opportunity after the presentation for media to conduct one-on-one interviews with Jeffrey Arterburn and other investigators who are a part of his team.